RXILIENT
LIVE

Serial Number

79439298

Owner

Rxilient Health Pte. Ltd.

Filing Date

Nov 19, 2025

Add to watchlist:

No watchlists yet
View on USPTO

RXILIENT Trademark

Serial Number: 79439298

RXILIENT is a trademark filed by Rxilient Health Pte. Ltd. on November 19, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Rxilient Health Pte. Ltd. (3 trademarks)

1 COLEMAN STREET,

Entity Type: 24

Trademark Details

Filing Date

November 19, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical drugs; pharmaceutical creams; pharmaceutical medicaments in unit dosage form; pharmaceutical preparations and substances; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for application to the skin; pharmaceutical preparations for health care; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the topical treatment of dermatological disorders; pharmaceuticals for ophthalmological use; biochemicals for pharmaceutical use; biological preparations for pharmaceutical purposes; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; preparations for the treatment of eye diseases; anti-cancer pharmaceutical preparations; capsules for veterinary pharmaceutical preparations; chemical preparations for pharmaceutical purposes; chemicals for pharmaceutical use; diagnostic agents for pharmaceutical use; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents that facilitate the delivery of pharmaceutical preparations; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; natural pharmaceutical preparations; chemical preparations for medical purposes; antibiotic dermatological products; antimicrobials for dermatologic use; barrier lotions for dermatological use; cortisone-based dermatological creams; creams for dermatological use; dermatologic preparations for medical purposes; dermatological pharmaceutical preparations; dermatological pharmaceutical products; external dermatological preparations; gels for dermatological use; hydrocortisone skin creams for dermatological use; injectable dermal fillers; medicated creams for treating dermatological conditions; medicated ointments for treating dermatological conditions; medicated lotions for treating dermatological conditions; pharmaceutical preparations for treating epidermal problems; pharmaceutical products for use in dermatology; skin patches for the transdermal delivery of pharmaceuticals; topical dermatological preparations for medical purposes; moisturisers [pharmaceuticals]; diagnostic preparations for medical use; medical preparations

Filing History

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 20, 2026 RFCS
REFUSAL PROCESSED BY MPU
May 20, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 1, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 31, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 19, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 19, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 18, 2025 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 11, 2025 SDRC